Stent thrombosis of drug eluting stent: Pathological perspective

Slides:



Advertisements
Similar presentations
PBL CV 2 Pathophysiology of coronary artery disease.
Advertisements

Clinical Trial Results. org Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation.
R4 하 상 진. Introduction Circulation May 1;115(17):
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Coronary Responses and Differential Mechanisms of.
Nat. Rev. Cardiol. doi: /nrcardio
Disclosure Statement of Financial Interest
Volume 60, Issue 3, Pages (September 2012)
Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular.
Arthur Vineberg, M.D., F.C.C.P., G.C. Mcmillan, M.D. 
Acute Left Main Coronary Occlusion Caused by Stent Fracture, Peri-Stent Aneurysm Formation, and Very-Late Stent Thrombosis: Revisiting the Dark Side of.
Volume 61, Issue 1, Pages (January 2013)
Acute coronary syndrome secondary to in-stent plaque rupture occurred at 9 years after deployment of bare metal stent  Hiroyuki Kunii, MD, Tetsuro Yokokawa,
Renu Virmani, MD. CVPath Institute, Inc. Gaithersburg, MD, USA.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease  Ralf.
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
Circumflex artery injury during mitral valve repair: Not well known, perhaps not so infrequent—lessons learned from a 6-case experience  Gonçalo F. Coutinho,
Stenting of Coronary Arteries in Non Stress/Benestent Disease
Circ Cardiovasc Interv
Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized clinical.
The OrbusNeich EPC Capture Biodegradable Polymer Sirolimus-eluting Stent Program Michael JB Kutryk, MD, PhD St Michael’s Hospital, Toronto.
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Tareq Ibrahim et al. JIMG 2009;2:
Glenn N. Levine et al. JACC 2016;68:
Chest Pain in a 39-Year-Old Man: What Could Be the Underlying Cause?
Implantable sensor for intraoperative and postoperative monitoring of blood flow: A preliminary report  Raphael S. Rabinovitz, PhD, Craig J. Hartley,
Volume 75, Issue 1, Pages 7-9 (January 2009)
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease  Ralf.
Left Main Coronary Artery Stent Thrombosis: A Challenging Case
Standardizing definitions for hybrid coronary revascularization
Gaku Nakazawa et al. JIMG 2009;2:
Late Coronary Stent Thrombosis Complicating Urologic Surgery
REALITY: 8 month results
International Journal of Cardiology
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Peter K. Smith, MD  The Annals of Thoracic Surgery 
Chapter 12 Pathophysiology of Atherosclerosis
Amar Krishnaswamy, MD  Interventional Cardiology Clinics 
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction  P.-G. Chassot, A. Delabays, D.R. Spahn 
Volume 383, Issue 9918, Pages (February 2014)
Impact of Platelet Reactivity Following Clopidogrel Administration
Aneurysm formation in experimental atherosclerosis: Relationship to plaque evolution  Christopher K. Zarins, MD, Seymour Glagov, MD, Dragoslava Vesselinovitch,
Patrick H McNulty, MD, Ian C Gilchrist, MD 
Bioresorbable Vascular Scaffolds in Cardiac Allograft Vasculopathy: A New Therapeutic Option  Flavio Ribichini, MD, Michele Pighi, MD, Giuseppe Faggian,
European Society of Cardiology Scientific Congress, September 2006
Percutaneous revascularization strategies in a patient with previous coronary artery bypass surgery: Technical and patho-physiological insights  Pierfrancesco.
Late Thrombosis in Drug Eluting Stents (DES)
A novel surgical approach to left main coronary artery giant aneurysm thrombosis in a child with a history of Kawasaki disease  Jay D. Pruetz, MD, Masato.
Preliminary experience with porcine intestinal submucosa (CorMatrix) for valve reconstruction in congenital heart disease: Histologic evaluation of explanted.
Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular.
Vein graft failure Journal of Vascular Surgery
Frequency-domain optical coherence tomography assessment of very late vascular response after carotid stent implantation  Guilherme F. Attizzani, MD,
Circumflex artery injury during mitral valve repair: Not well known, perhaps not so infrequent—lessons learned from a 6-case experience  Gonçalo F. Coutinho,
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Seung-Yul Lee et al. JCIN 2018;j.jcin
Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent- mediated delivery of everolimus  Hugh Q. Zhao, PhD, Alexander.
Matadial Ojha, PhD, Richard L Leask, K
Nat. Rev. Cardiol. doi: /nrcardio
Histopathology of the Longest-Lived Saphenous Vein Graft in a Patient With Kawasaki Disease  Satoru Domoto, MD, Kiyoharu Nakano, MD, Kojiro Kodera, MD,
Evaluation of a novel device for left atrial appendage exclusion: The second-generation atrial exclusion device  Keiji Kamohara, MD, Kiyotaka Fukamachi,
Acute Left Main Coronary Occlusion Caused by Stent Fracture, Peri-Stent Aneurysm Formation, and Very-Late Stent Thrombosis: Revisiting the Dark Side of.
Richard L. Binns, MD  Journal of Vascular Surgery 
Joseph J. Piotrowski, MD, Glenn C. Hunter, MD, Cleamond D
Marc Ruel, MD, MPH, Masood A
The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization  Lorenzo Azzalini,
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Giant atherosclerotic aneurysm of the left anterior descending artery
Brian W. McCrindle, MD, MPH, Kevin C. Harris, MD 
Spontaneous Coronary Artery Dissection
Presentation transcript:

Stent thrombosis of drug eluting stent: Pathological perspective Gaku Nakazawa, MD  Journal of Cardiology  Volume 58, Issue 2, Pages 84-91 (September 2011) DOI: 10.1016/j.jjcc.2011.07.004 Copyright © 2011 Terms and Conditions

Figure 1 Histologic sections in the top row (A, B, and C) are from patients with acute myocardial infarction. A 64-year-old female who died from congestive heart failure 9 months after Taxus stent implantation (A), a 49-year-old male who died from non-cardiac cause 13 months after Cypher stent implantation (B), and a 34-year-old female who died from late stent thrombosis 24 months after Cypher stent implantation (C). Struts with necrotic core (NC) were observed with fibrin deposition and absence of endothelial coverage (A). Stents in (B) and (C) showed minimal coverage of struts above necrotic core at 13 or 24 months duration. Histologic sections in the bottom row (D, E, and F) are from patients with stable lesions. A 61-year-old male who died from a non-cardiac cause 7 months after Cypher stent implantation (D), a 53-year-old male who died suddenly 18 months after Taxus stent implantation (E), and a 68-year-old male who died from a non-cardiac cause 19 months after Cypher stent implantation (F). All patients had underlying fibroatheroma with thick fibrous cap (FC). High magnification images show underlying NC and thick FC with varying degrees of neointimal formation above stent struts (D, E, and F). Reproduced, with permission, from Nakazawa et al. [13]. Journal of Cardiology 2011 58, 84-91DOI: (10.1016/j.jjcc.2011.07.004) Copyright © 2011 Terms and Conditions

Figure 2 (A) Histologic sections from sirolimus-eluting stent (SES). A 40-year-old female, who received 2 SES in the left anterior descending artery (LAD) and right coronary artery (RCA) 17 months antemortem, died suddenly 4 days following surgical removal of melanoma (wide excision). Anti-platelet therapy (aspirin and clopidogrel) was discontinued 5 days before the surgery. Histologic sections of the SES in LAD showed total thrombotic occlusion and diffuse inflammation (a). Numerous inflammatory cells were observed within the neointimal area (b). Inflammatory reaction predominantly consists of T-lymphocytes (c; CD45Ro) and eosinophils (d; Luna stain). Note, the same reaction was observed in the SES in RCA (e) and severe inflammation resulted in malapposition of stent struts (f). (B) Histologic sections from paclitaxel-eluting stent (PES) showing malapposition. A 69-year-old male, who received PES in saphenous vein graft, died suddenly 3 months after the stent placement. Histologic sections showed thrombotic occlusion in the PES (a and b); note, malapposition secondary to severe fibrin deposition (c). A 48-year-old male with PES implantation in the proximal LAD died suddenly at 40 months. Histologic sections showed thrombotic occlusion of the PES (d). Most struts are malapposed with fibrin deposition underneath the stent struts (e and f). Thr, thrombus. Reproduced, with permission, from Nakazawa et al. [12]. Journal of Cardiology 2011 58, 84-91DOI: (10.1016/j.jjcc.2011.07.004) Copyright © 2011 Terms and Conditions

Figure 3 Histologic sections with Taxus stent implanted in the left circumflex artery 14 months antemortem. A low power image shows a patent lumen with moderate neointimal growth (A), foamy macrophage infiltration and necrotic core formation with cholesterol clefts is seen at high magnification in (B). Histologic sections with Cypher stent implanted 13 months antemortem. A low power image shows in-stent restenosis (C), necrotic core formation within the intimal tissue is observed (D). Journal of Cardiology 2011 58, 84-91DOI: (10.1016/j.jjcc.2011.07.004) Copyright © 2011 Terms and Conditions

Figure 4 The timing and mechanisms of stent thrombosis in the drug-eluting stent (DES) era. Journal of Cardiology 2011 58, 84-91DOI: (10.1016/j.jjcc.2011.07.004) Copyright © 2011 Terms and Conditions